

Improving the health of our patients through groundbreaking clinical research
The Schweiger Dermatology Group (SDG) Clinical Research Department Research Clinic is led by Dr. David Goldberg, founder of Skin, Laser and Surgery Specialist of New York and New Jersey. Dr. Goldberg brings more than 25 years of experience in conducting large multi-center clinical trials on a wide variety of cosmetic and medical devices, as well as pharmaceutical treatments. Our research team is committed to responsible research conducted under strict industry and safety standards.
Purpose: The purpose of this study is to evaluate the impact of Mind.Px on response to biologic treatment for patients suffering from plaque psoriasis, as judged by the mean change in the Psoriasis Area Severity index (PASI) score from baseline to end of Week 16 of the study.
Qualifications:
Duration: Up to 20 weeks
Location: Hackensack, NJ
Compensation: Up to $630 will be paid to the patient *once all visits are completed*
Interested in participating in our clinical research study? Please click here.
Purpose: The purpose of this investigation is to evaluate the Dermal Cooling System for the treatment of Psoriasis in adult subjects, to verify that exposure to controlled cold conditions will elicit improvement in the cosmetic appearance or physical symptoms of patients affected by this skin condition.
Qualifications:
Duration: Approximately 12 months
Location: Hackensack, NJ
Compensation: $50 per visit
Interested in participating in our clinical research study? Please click here.
Purpose: This study is being done to evaluate the safety and tolerability of RPT193 in subjects with moderate to severe atopic dermatitis, also known as eczema. Investigational product will be administered as monotherapy for AD in adult patients who have had an inadequate response to topical medications for AD (e.g., corticosteroids) or who are otherwise unable to take topical medications.
Qualifications:
Duration: Up to 7 months
Location: Hackensack, NJ
Compensation: Up to $650
Interested in participating in our clinical research study? Please click here.
Purpose: This study is being done to evaluate the safety and tolerability of Rocatinlimab (AMG 451) in subjects with moderate to severe atopic dermatitis, also known as eczema. Investigational product will be administered as monotherapy for AD in combination with topical corticosteroids/topical calcineurin inhibitor. This is a placebo-controlled, double-blind study.
Qualifications:
Duration: Approximately 6 months
Location: Hackensack, NJ
Compensation: $30 per visit will be paid to the patient *once all visits are completed*
Interested in participating in our clinical research study? Please click here.
Purpose: This study is being done to evaluate to evaluate the efficacy of 2 dose levels of oral difelikefalin as adjunct therapy to a topical corticosteroid (TCS), compared to placebo and to TCS alone, in reducing the intensity of itch after 12 weeks of treatment for moderate-to-severe pruritus in adult subjects with atopic dermatitis (AD).
Qualifications:
Duration: Approximately 4 months
Location: Hackensack, NJ
Compensation: $68 per visit will be paid to the patient *once all visits are completed*
Interested in participating in our clinical research study? Please click here.
Interested in participating in our clinical research study? Please click here.
To learn more contact: Diana Aranzazu, [email protected], 609-219-5621
All Rights Reserved. Web Design & Internet Marketing by Studio III
The health and safety of our patients and staff is our top priority. Our in-office safety policies are aligned with the latest guidelines issued by the CDC and local government officials related to COVID-19.
New safety policies for patients:
New safety policies for office & staff: